(Q51069716)
Statements
1 reference
Clinical impact of continued crizotinib administration after isolated central nervous system progression in patients with lung cancer positive for ALK rearrangement. (English)
1 reference
Masayuki Takeda
1 reference
Isamu Okamoto
1 reference
Kazuhiko Nakagawa
1 reference
1 May 2013
1 reference
8
1 reference
654-657
1 reference
5
1 reference
Identifiers
1 reference